最新发布第6页
AEON Biopharma Reports Disappointing Interim Phase 2 Results of Migraine Preventive ABP-450-爱医学

AEON Biopharma Reports Disappointing Interim Phase 2 Results of Migraine Preventive ABP-450

Newly announced preliminary top-line results from a planned interim analysis of a phase 2 study (NCT04845178) showed that treatment with ABP-450 (AEON Biopharma) did not meet its p...
NeuroVoices: Kayla Scippa, on Recognizing Unmet Need in Chronic Demyelinating Polyneuropathy-爱医学

NeuroVoices: Kayla Scippa, on Recognizing Unmet Need in Chronic Demyelinating Polyneuropathy

Chronic demyelinating polyneuropathy (CIDP) is a neuromuscular disorder characterized by progressive weakness and impaired sensory function in the arms and legs. It is an autoimmun...
Understanding the Root of REM Behavior Disorder and Other Parasomnias-爱医学

Understanding the Root of REM Behavior Disorder and Other Parasomnias

Parasomnias are sleep disorders that involve abnormal behaviors, emotional experiences, perceptions, and dream activity, occurring during specific sleep stages or sleep-wake transi...
SAGE-324/BIIB124 Significantly Reduces Upper Limb Tremor in Phase 2 KINETIC Trial-爱医学

SAGE-324/BIIB124 Significantly Reduces Upper Limb Tremor in Phase 2 KINETIC Trial

Helen Colquhoun, MD(Credit: LinkedIn)Recently published in Movement Disorders, results from the double-blind, randomized, placebo-controlled, phase 2 KINETIC trial (NCT04305275) as...
Anesthesiology丨麻醉诱导中的脑电图生物标志物可识别术后谵妄风险的易感患者-爱医学

Anesthesiology丨麻醉诱导中的脑电图生物标志物可识别术后谵妄风险的易感患者

术后神经认知障碍是一种复杂的疾病,包括术后谵妄(POD)和术后神经认知功能障碍。高达50%的老年患者在手术干预后出现POD,这与发生长期不良结局的风险相关。由于患者仅表现为运动功能减退,导致P...
eason的头像-爱医学eason1年前
6313
ALS Candidate PrimeC Shows Greater Treatment Effect in High-Risk ALS-爱医学

ALS Candidate PrimeC Shows Greater Treatment Effect in High-Risk ALS

Jeremy M. Shefner, MD, PhDNewly announced analyses from the phase 2b PARADIGM trial (NCT05357950) showed that treatment with PrimeC (NeuroSense), an investigational agent made up o...
Early Treatment Response and Safety Profile of AXS-05 in Phase 3 ACCORD Trial: Anton P. Porsteinsson, MD-爱医学

Early Treatment Response and Safety Profile of AXS-05 in Phase 3 ACCORD Trial: Anton P. Porsteinsson, MD

WATCH TIME: 6 minutes'It's important because when patients finally seek treatment for agitation and aggression that’s been going on for quite a while and has gotten to a critical ...
Crossover Study Highlights Pharmacokinetic Effects of DHE Powder STS101-爱医学

Crossover Study Highlights Pharmacokinetic Effects of DHE Powder STS101

A recently published, randomized, open-label, 5-period crossover study showed that treatment with STS101, an intranasal dihydroergotamine (DHE) powder, was safe in healthy particip...
Negative Myoclonus Associated With Severe Motor Implications in Progressive Myoclonus Ataxia-爱医学

Negative Myoclonus Associated With Severe Motor Implications in Progressive Myoclonus Ataxia

Marina A.J. Tijssen, MD, PhD(Credit: University of Groningen)In a newly published study in Movement Disorders, patients with progressive myoclonus ataxia (PMA) affected by negative...
Anesthesia & Analgesia丨产妇出院后处方阿片类药物使用的普遍性和持续性:一项基于澳大利亚人群的队列研究-爱医学